Patents by Inventor Mary J. Ruwart

Mary J. Ruwart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7390507
    Abstract: The present invention relates to compositions and methods for the treatment of traumatic conditions of the skin including radiation dermatitis, thermal burn, sunburn, dermatomyo-fibromas, and exposure-induced wrinkles, comprising omega-3 fish oils, tocopherols, lavender oil and a suitable amount of a pharmaceutically acceptable carrier, and optionally, one or more of the following: Sodium PCA, or MSM.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: June 24, 2008
    Inventor: Mary J. Ruwart
  • Patent number: 5124158
    Abstract: A method for the treatment of gastrointestinal disease through a transdermally administered antisecretory agent. Antisecretory agents useful for transdermal administration are substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles and omeprazole.
    Type: Grant
    Filed: December 20, 1990
    Date of Patent: June 23, 1992
    Assignee: The Upjohn Company
    Inventors: Mary J. Ruwart, Wha B. Im
  • Patent number: 4496587
    Abstract: The present invention provides a method for inhibiting the synthesis and release of toxins from bacteria which comprises contacting the bacteria with an antitoxic prostaglandin.
    Type: Grant
    Filed: April 29, 1983
    Date of Patent: January 29, 1985
    Assignee: The Upjohn Company
    Inventors: Harold E. Renis, Mary J. Ruwart
  • Patent number: 4374856
    Abstract: The present invention provides a method for treatment of hepatic diseases which comprises administering a hepatocytoprotective prostaglandin to a mammal who suffers from or is particularly succeptible to said hepatic diseases.
    Type: Grant
    Filed: September 10, 1980
    Date of Patent: February 22, 1983
    Assignee: The Upjohn Company
    Inventor: Mary J. Ruwart
  • Patent number: 4359465
    Abstract: The present invention relates to the novel cytoprotective use for known heterocyclyalkylsulfinylbenzimidazoles, and novel, substantially non-antisecretory unit dose pharmaceutical compositions thereof.
    Type: Grant
    Filed: July 28, 1980
    Date of Patent: November 16, 1982
    Assignee: The Upjohn Company
    Inventor: Mary J. Ruwart